TauRx Pharmaceuticals (Singapore)

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Joshua A Welsh, Deborah C. I. Goberdhan, Lorraine O’Driscoll et al. · Journal of Extracellular Vesicles · 2024 · 3K citations · Full text

Protein Secretion, Minimal Information, Immunology +24

Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells

Takahiro Kamiya, See Voon Seow, Desmond Wong et al. · Journal of Clinical Investigation · 2019 · 331 citations · Full text

O3‐04–07: Tau aggregation inhibitor (TAI) therapy with rember^™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks

Claude M. Wischik, Peter Bentham, Damon Wischik et al. · Alzheimer s & Dementia · 2008 · 119 citations · Full text

Disease Progression, Moderate Alzheimer, Geriatric Neurology +20

International Communication: English Language Challenges for Malaysia

Ho Wah Kam · Asian Englishes · 2003 · 78 citations

Multicultural Communication, Asian Englishes, Multilingualism +8

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia

Jianbiao Zhou, Jessie Yiying Quah, Yvonne Ng et al. · Haematologica · 2019 · 78 citations · Full text

Hematological Malignancy, Dihydroorotate Dehydrogenase, Chemoprevention Strategy +12